InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 20.16
-1.09 (-5.13%)
At close: Jul 31, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 11.66 billion as of July 31, 2026. Its market cap has decreased by -56.12% in one year.
Market Cap
11.66B
Enterprise Value
10.30B
Revenue
71.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.16
ChartMarket Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 11.66B, an increase of 32.62%. That is a compound annual growth rate of 7.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 11.66B | -25.99% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightGene Bio-Medical Technology | 13.85B |
| Jinyu Bio-technology | 13.81B |
| Anhui Anke Biotechnology (Group) | 13.72B |
| Mabwell (Shanghai) Bioscience | 12.23B |
| Tibet Cheezheng Tibetan Medicine | 11.89B |
| Inner Mongolia Furui Medical Science | 11.47B |
| Chengzhi | 11.06B |
| HitGen | 10.54B |